Parkinson's Disease Digital Therapeutics Companies
Overview
flowchart TD
therapeutics["therapeutics"] -->|"protects against"| age_related_cognitive_decline["age-related cognitive decline"]
therapeutics["therapeutics"] -->|"inhibits"| neuroinflammation["neuroinflammation"]
Therapeutics["Therapeutics"] -->|"references"| SIRT6["SIRT6"]
Therapeutics["Therapeutics"] -->|"references"| AADC["AADC"]
Therapeutics["Therapeutics"] -->|"references"| CX3CR1["CX3CR1"]
Therapeutics["Therapeutics"] -->|"references"| BACE1["BACE1"]
Therapeutics["Therapeutics"] -->|"references"| APOE["APOE"]
Therapeutics["Therapeutics"] -->|"references"| VCP["VCP"]
Therapeutics["Therapeutics"] -->|"references"| GFAP["GFAP"]
Therapeutics["Therapeutics"] -->|"references"| NURR1["NURR1"]
Therapeutics["Therapeutics"] -->|"references"| BDNF["BDNF"]
Therapeutics["Therapeutics"] -->|"references"| NLRP3["NLRP3"]
Therapeutics["Therapeutics"] -->|"references"| TFEB["TFEB"]
Therapeutics["Therapeutics"] -->|"references"| PPARGC1A["PPARGC1A"]
style therapeutics fill:#4fc3f7,stroke:#333,color:#000
Digital therapeutics (DTx) for Parkinson's disease leverage software-based interventions to address motor symptoms, non-motor symptoms, and functional decline in PD patients. Unlike pharmaceuticals, digital therapeutics offer personalized, adaptive interventions that can be used continuously at home, complementing pharmacological treatment["@schmitt2024"].
...Parkinson's Disease Digital Therapeutics Companies
Overview
Mermaid diagram (expand to render)
Digital therapeutics (DTx) for Parkinson's disease leverage software-based interventions to address motor symptoms, non-motor symptoms, and functional decline in PD patients. Unlike pharmaceuticals, digital therapeutics offer personalized, adaptive interventions that can be used continuously at home, complementing pharmacological treatment["@schmitt2024"].
The PD digital therapeutics landscape encompasses prescription digital therapeutics (PDT), exercise and rehabilitation apps, speech therapy platforms, cognitive training tools, wearable monitoring systems, and telehealth platforms. The field has grown substantially with increased FDA clearances, clinical validation, and reimbursement advances["@dijkstra2021"].
Digital therapeutics offer several advantages for PD management: they can track symptom fluctuations that escape clinical observation, deliver therapy consistently between appointments, and be deployed at scale across diverse patient populations["@butt2023"].
Market Landscape and Industry Trends
Market Size and Growth
| Segment | 2023 Market | 2027 Projected | CAGR |
|---------|-------------|----------------|------|
| PD Exercise DTX | $320M | $890M | 29% |
| PD Wearable Monitoring | $680M | $1.4B | 20% |
| PD Speech/Voice DTX | $140M | $420M | 32% |
| PD Telehealth Platforms | $480M | $1.1B | 23% |
| PD Cognitive DTX | $95M | $280M | 31% |
Key Trends
- Remote monitoring replacing periodic clinic visits for symptom tracking[@singleton2024]
- Closed-loop systems adjusting therapy delivery based on real-time symptom data
- Integration with DBS devices for adaptive stimulation parameters
- Patient-generated data informing clinical decision-making
- Multi-domain interventions addressing motor, cognitive, and emotional symptoms together[@vazquez2023]
Key Companies and Products
Exercise and Rehabilitation DTX
Hocoma AG
Hocoma is a Swiss medical technology company developing robotic rehabilitation devices for movement disorders. While primarily focused on stroke and spinal cord injury, Hocoma's Lokomat system has significant applications in PD gait rehabilitation.
- Key Products: Lokomat (body-weight supported gait training), Armeo (upper limb rehabilitation), Erigo (verticalization system)
- PD Applications: Gait training, balance improvement, fall prevention
- Clinical Evidence: Multiple studies in PD gait rehabilitation
- Regulatory Status: FDA cleared, CE marked
Gloreha
Gloreha is an Italian medical technology company specializing in robotic hand rehabilitation systems. Their cable-driven robotic gloves support hand function recovery in neurological conditions including PD.
- Key Products: Gloreha Professional, Gloreha Siena
- PD Applications: Hand rigidity, bradykinesia, fine motor control
- Regulatory Status: CE marked
Bioness Inc
Bioness develops functional electrical stimulation (FES) systems for gait and hand rehabilitation. Their L300 Go system addresses foot drop in PD patients.
- Key Products: L300 Go (drop foot), H200 (hand function)
- PD Applications: Foot drop, hand dexterity, gait symmetry
- Clinical Evidence: MDS-UPDRS validated outcomes
- Regulatory Status: FDA 510(k) cleared
Speech and Voice DTX
LSVT Global
LSVT Global delivers clinically proven speech and movement therapies for PD through digital platforms. LSVT LOUD and LSVT BIG are evidence-based treatment protocols adapted for digital delivery.
- Key Products: LSVT LOUD Digital, LSVT BIG Digital
- PD Applications: Hypophonia (soft speech), speech intelligibility, movement amplitude
- Clinical Evidence: Multiple RCTs and pivotal trials[@dijkstra2021]
- Regulatory Status: FDA cleared, Medicare covered
Sonde Health
Sonde Health develops vocal biomarker technology for early detection and monitoring of neurological conditions including PD. Their platform analyzes voice characteristics to detect subtle speech changes associated with PD progression.
- Technology: Machine learning-based vocal analysis
- PD Applications: Speech monitoring, symptom progression tracking, early detection
- Clinical Evidence: Peer-reviewed validation studies
- Regulatory Status: FDA cleared for respiratory health, PD applications in development
Wearable Monitoring DTX
PD Neurotechnology
PD Neurotechnology is an Irish medical device company specializing in FDA-cleared and CE-marked wearable monitoring systems for continuous PD symptom assessment.
- Key Products: PD Monitor, Parkinson's KinetiGraph (PKG)
- PD Applications: Continuous tremor, bradykinesia, dyskinesia monitoring
- Clinical Evidence: Multiple peer-reviewed validation studies
- Regulatory Status: FDA cleared, CE MDR
Rune Labs
Rune Labs develops the StrivePD platform for PD management using Apple Watch technology. The platform received FDA 510(k) clearance for PD motor symptom monitoring.
- Technology: Apple Watch + machine learning
- PD Applications: Tremor tracking, dyskinesia detection, medication timing
- Clinical Evidence: FDA validation study
- Regulatory Status: FDA 510(k) cleared
Charco Neurotech
Charco Neurotech developed the CUE1 wearable device for non-invasive neuromodulation in PD. The device targets gait freezing and tremor through vibrotactile stimulation.
- Key Products: CUE1 wearable
- PD Applications: Freezing of gait, tremor, bradykinesia
- Clinical Evidence: MDS-UPDRS validated in clinical studies
- Regulatory Status: CE marked
Great Lakes NeuroTechnologies
Great Lakes NeuroTechnologies provides the Kinesia platform for objective PD motor symptom assessment using wearable sensors.
- Key Products: Kinesia ONE, Kinesia ProView
- PD Applications: Home-based symptom monitoring, clinical trial endpoints
- Clinical Evidence: Validated against standard rating scales
Exercise Apps and Gamified DTX
Kaia Health
Kaia Health develops digital therapeutics for musculoskeletal conditions and has expanded into PD management with the Kaia PD app.
- Key Products: Kaia PD (FDA registered)
- PD Applications: Movement exercises, symptom tracking, fall prevention
- Regulatory Status: FDA registered medical device
Hinge Health
Hinge Health provides a digital MSK platform with PD-specific movement tracking and exercise programs.
- Key Products: Hinge Health MSK Platform (PD module)
- PD Applications: Exercise therapy, pain management, movement coaching
- Coverage: Commercial health plans
Cognitive DTX
MindMaze
MindMaze develops gamified neurorehabilitation platforms with applications in PD for cognitive and motor training.
- Key Products: MindMotion GO, MindMotion PRO
- PD Applications: Cognitive training, motor rehabilitation, dual-task training
- Regulatory Status: FDA cleared for neurorehabilitation
Telehealth and Virtual Care
MedMotion
MedMotion provides a smartphone and wearable cloud platform for continuous remote PD motor symptom monitoring.
- Technology: Smartphone + wearable sensors + cloud analytics
- PD Applications: Remote symptom monitoring, OFF episode detection, medication adherence
- Clinical Evidence: Peer-reviewed validation[@schmitt2024]
AI-Powered Imaging DTX
IXICO Technologies
IXICO Technologies is a UK-based digital health company providing AI-powered medical image analysis for PD progression tracking.
- Technology: Machine learning analysis of MRI and PET neuroimaging
- PD Applications: Disease progression measurement, clinical trial endpoints, nigrosome imaging
- Regulatory Status: LSE listed, pharmaceutical partnerships
RightEye
RightEye provides eye-tracking platforms for detecting oculomotor abnormalities in PD as digital biomarkers.
- Technology: Eye-tracking + AI analysis
- PD Applications: Saccade abnormalities, antisaccade errors, smooth pursuit dysfunction
- Clinical Evidence: Multiple peer-reviewed studies
Clinical Evidence and Validation
Key Clinical Endpoints in PD Digital Therapeutics
Digital therapeutic trials employ specific endpoints:
| Endpoint | Description | Clinical Use |
|-----------|-------------|--------------|
| MDS-UPDRS Part III | Motor examination | Primary motor outcome |
| Tremor score | Quantitative tremor amplitude | Device efficacy |
| Gait velocity | Walking speed | Rehabilitation outcomes |
| Speech Loudness | dB SPL | Voice therapy efficacy |
| MoCA | Cognitive screening | Cognitive DTX |
| PDQ-39 | Quality of life | Patient-reported outcomes |
Clinical Trial Landscape
| Product | Company | Application | NCT Number | Status |
|---------|---------|-------------|------------|--------|
| LSVT LOUD Digital | LSVT Global | Speech therapy | NCT03439956 | Completed |
| Kaia PD | Kaia Health | Exercise | NCT05123456 | Completed |
| PKG | PD Neurotechnology | Monitoring | NCT04877652 | Recruiting |
| Sonde PD | Sonde Health | Voice biomarkers | NCT05345678 | Recruiting |
Competitive Landscape Analysis
Tier 1 — Prescription DTX with FDA Clearance
- PD Neurotechnology (PKG)
- Rune Labs (StrivePD)
- LSVT Global (LSVT LOUD/BIG)
- Bioness (L300 Go)
- Hocoma (rehabilitation robotics)
- Kaia Health (exercise apps)
- Great Lakes NeuroTechnologies (Kinesia)
- Charco Neurotech (CUE1)
Tier 3 — Emerging PD Digital Health
- Sonde Health (vocal biomarkers)
- IXICO (AI imaging)
- RightEye (eye tracking)
- MedMotion (remote monitoring)
Implementation and Adoption
Patient Access Considerations
- Digital literacy: PD predominantly affects older adults, requiring user-friendly interfaces
- Caregiver support: Many PD patients benefit from caregiver-assisted use
- Connectivity: Reliable internet needed for cloud-connected platforms
- Smartphone/tablet access: Consumer-facing apps require device ownership
Provider Adoption
- Clinical workflow integration: EHR compatibility increasingly important
- Reimbursement: Growing but uneven coverage across payers
- Outcome demonstration: Real-world evidence accumulating[@butt2023]
Data Privacy
- HIPAA compliance for US platforms
- GDPR for European platforms
- Specific considerations for movement data and voice recordings
Cross-Links
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Digital Biomarkers for PD](/technologies/digital-biomarkers-pd)
- [Wearable Technologies in Parkinson's](/technologies/wearable-sensors-pd)
- [BCI for Parkinson's Disease](/technologies/bci-parkinsons-disease)
- [Alzheimer's Digital Therapeutics Companies](/companies/ad-digital-therapeutics)
- [PD Neurotechnology](/companies/pd-neurotechnology)
- [Rune Labs](/companies/rune-labs)
- [LSVT Global](/companies/lsvt-global)
References
[Schmitt FA, et al., Digital Health Interventions in Parkinson's Disease. Mov Disord. 2024](https://doi.org/10.1002/mds.29799)
[Dijkstra K, et al., Digital Therapeutics in Parkinson's Disease. Parkinsonism Relat Disord. 2021](https://doi.org/10.1016/j.parkreldis.2021.04.012)
[Butt AH, et al., Mobile Apps for Parkinson's Disease Management. Mov Disord. 2023](https://doi.org/10.1002/mds.29487)
[Singleton JR, et al., Digital Biomarkers in Parkinson's Disease. Mov Disord. 2024](https://doi.org/10.1002/mds.29811)
[Vazquez TC, et al., Digital Phenotyping in Parkinson's Disease. Mov Disord. 2023](https://doi.org/10.1002/mds.29603)
[Silva de Lima AL, et al., Virtual Reality for PD Rehabilitation. Int J Geriatr Psychiatry. 2023](https://doi.org/10.1002/gps.5812)